Status:
UNKNOWN
Bioenergetics in Surgical Patients
Lead Sponsor:
University of South Alabama
Conditions:
Mitochondrial DAMP Levels in Surgical Patients
Eligibility:
All Genders
19-80 years
Phase:
NA
Brief Summary
To identify patients who may be predisposed for developing MOF (multiple organ failure)by the sampling of blood.
Detailed Description
The rationale for doing this study is the recognition that mitochondrial DNA Damage Associated Molecular Patterns (mtDAMPs) accumulate in the circulation after severe injury. Furthermore our own studi...
Eligibility Criteria
Inclusion
- Patients @ USAMC undergoing surgical operations expected to have microcirculatory changes, i.e., CABG, open heart, aortic or other revascularizing operations, general surgical operations such as colon resections, bowel resections or any other surgical procedures in which the subject could be expected to or might develop multiple system organ failure.
Exclusion
- N/A
Key Trial Info
Start Date :
December 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2019
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT01890395
Start Date
December 1 2012
End Date
December 1 2019
Last Update
August 17 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of South Alabama Medical Center
Mobile, Alabama, United States, 36617